400-P: More Pronounced Effect of Empagliflozin-Losartan Combination Therapy on Measured GFR and Blood Pressure vs. Either of the Drugs: A Crossover RCT in People with Type 2 Diabetes

求助中 20 由讨厌早起发布于 2026/7/21 8:00:19

DOI:10.2337/db22-400-p
作者：D. V. van Raalte,?H. Heerspink,?R. Scholtes
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Introduction: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and renin-angiotensin system inhibitors (RASi) improve kidney outcomes in people with type 2 diabetes (T2D) . Both drugs favo

应助信息

等您来应助

上传文件

20小时前

Book学术机器人

2026/7/21 8:00:20 未找到该文献，机器人已退出，请等待人工下载

2026/7/21 8:00:20 Book学术AI机器人收到请求，开始寻找文献

2026/7/21 8:00:20 已向机器人发送请求

20小时前

讨厌早起发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for the Advancement of Science (AAAS)Harnessing semen-derived exosomes for noninvasive fundus drug delivery: A paradigm for exosome-based ocular fundus therapeutics